References
- Omron NE-U22 MicroAir product brochure. Vernon Hills, IL. Omron Healthcare Inc. www.quickmedical.com/downloads/omron-respiratory-neu22v_brochure.pdf.
- Ingram H: Nebulisers–World–2014 [Internet]. IHS Technology (2014). https://technology.ihs.com/435839/nebulizers-2014.
- Executive summary: European anesthesia, respiratory and sleep management device markets. iData research Inc., Burnaby, BC, Canada (2011).
- Kesser KC Geller DE . New aerosol delivery devices for cystic fibrosis. Respir Care.54 (6), 754–767 (2009).
- Hess DR . Aerosol delivery devices in the treatment of asthma. Respir Care.53 (6), 699–723 (2008).
- Elphick M von Hollen D Pritchard JN Nikander K Hardaker LEA Hatley RHM . Factors to consider when selecting a nebulizer for a new inhaled drug product development program. Expert Opin. Drug Deliv.12 (8), 1375–1387 (2015).
- Rayleigh JW . On the instability of jets. Proc. London Math Soc.10 (1), 4–13 (1878).
- MicroAIR U22 (2017). www.omron-healthcare.com/en/products/respiratorytherapy#.
- I-neb AAD System (2017). www.philips.co.uk/healthcare/solutions/sleep-and-respiratory-care/respiratory-drug-delivery.
- InnoSpire Go (2017). www.philips.co.uk/c-p/HH1342_00/innospire-go-portable-mesh-nebuliser.
- eFlow rapid nebuliser system (2017). www.pari.com/de-en/products/lower-airways/eflow-rapid-nebuliser-system/.
- Fox (2017). www.vectura.com/technologies/device-technologies/nebuliser/.
- Aerogen Solo (2017). www.aerogen.com/aerogen-solo-3/.
- Medical Expo Vibrating mesh nebulizers (2017). www.medicalexpo.com/medical-manufacturer/vibrating-mesh-nebulizer-30663.html.
- Dhand R . Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care.47 (12), 1406–1416 (2002).
- Omron MicroAir portable nebulizer model NE-U03V instruction manual. Omron Healthcare Inc., Vernon Hills, IL, USA.
- OMRON HEALTHCARE CO LTD: EP-1327480 (2003).
- Denyer J Dyche T . The adaptive aerosol delivery (AAD) technology: past, present and future. J. Aerosol. Med. Pulm. Drug Deliv.23 (Suppl. 1), S1–S10 (2010).
- Hardaker LEA Hatley RHM . In vitro characterization of the I-neb adaptive aerosol delivery (AAD) system. J. Aerosol. Med. Pulm. Drug Deliv.23 (Suppl. 1), S11–S20 (2010).
- RESPIRONICS RESPIRATORY DRUG DELIVERY (UK) LTD: EP-1465692 (2004).
- Evaluate Ltd . Aerogen and medical industries America announce USA introduction of Aeroneb Go nebulizer (2004). www.evaluategroup.com/Universal/View.aspx?type=Story&id=71104.
- Koninklijke Philips N.V . Philips strengthens home healthcare solutions business through agreement with Aerogen (2014). www.newscenter.philips.com/gb_en/standard/news/press/2014/20140107-philips-strengthens-home-healthcare-solutions-business-through-agreement-with-aerogen.wpd#.VNoJ8y57LIU.
- Hatley R Rowe L Rabbetts I Quadrelli F . Optimizing patient experience of nebulizer treatments. Eur. Respir. J.48 (Suppl. 60), PA4082 (2016).
- Lass JS Sant A Knoch M . New advances in aerosolized drug delivery: vibrating membrane nebuliser technology. Expert Opin Drug Deliv.3 (5), 693–702 (2006).
- PARI GMBH: US6962151 (2005).
- THE TECHNOLOGY PARTNERSHIP: US7316067 (2008).
- Acquisition of Activaero (2014). www.vectura.com/news/acquisition-activaero/.
- Bennett WD . Controlled inhalation of aerosolised therapeutics. Expert Opin. Drug Deliv.2 (4), 763–767 (2005).
- First launch of a product incorporating Vectura's FOX smart nebuliser technology (2017). www.vectura.com/news/first-launch-product-incorporating-vecturas-fox-smart-nebuliser-technology/.
- Evaluate Ltd . Aerogen introduces the Aeroneb Pro for respiratory therapy in the hospital (2002). www.evaluategroup.com/Universal/View.aspx?type=Story&id=71142.
- STAMFORD DEVICES LTD: EP-2624967 (2013).
- NOVARTIS AG: US7971588 (2011).
- KONINKLIJKE PHILIPS ELECTRONICS N.V.: USD683012S (2013).
- Medical Expo: vibrating mesh nebulizers. www.medicalexpo.com/medical-manufacturer/vibrating-mesh-nebulizer-30663.html.
- Berg EB Picard RJ . In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns. Respir. Care.54 (12), 1671–1678 (2009).
- Loffert DT Ikle D Nelson HS . A comparison of commercial jet nebulizers. Chest.106 (6), 1788–1792 (1994).
- Hatley RHM Hardaker LEA Zarins-Tutt J et al. Investigation of optical density for the characterization of nebulizer meshes. In : Respiratory Drug Delivery 2016. DalbyRNByronPRPeartJSumanJDYoungPMTrainiD ( Eds). Proceedings of Respiratory Drug Delivery 2016. Scottsdale, AZ, USA, 17–21 April 2016. Virginia Commonwealth University, Richmond, VA, USA, 489–492 (2016).
- Keller M Tservistas M Bitterle E Bauer S . Aerosol characterization of Alpha-1 antitrypsin after nebulization with the eFlow: a novel vibrating perforated membrane nebulizer. In : Respiratory Drug Delivery 2006. DalbyRNByronPRPeartJSumanJDFarrSJ ( Eds). Proceedings of Respiratory Drug Delivery 2006. Boca Raton, FL, USA, 23–27 April 2006. Virginia Commonwealth University, Richmond, VA, USA, 733–736 (2006).
- Fink JB Simmons R . Nebulization of steroid suspension: an in vitro evaluation of the aeroneb go and the pari LC plus nebulizers. Chest126 (4), 816S–817S (2004).
- Hibbitts A Sivadas N Tewes F et al. Investigation of fluid physicochemical properties on output in vibrating mesh nebulisers. J. Aerosol. Med. Pulm. Drug Deliv.24 (3), A48–A49 (2011).
- INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE: US7669782 (2010).
- Newman S Pitcairn G Pickford M Gee-Turner A Asai K . The MicroAir electronic-mesh nebuliser deposits aerosol in the lungs more efficiently than a conventional jet nebuliser. J. Aerosol. Med. Pulm. Drug Deliv.18 (2), 249 (2005).
- Ari A . Jet, ultrasonic and mesh nebulizers: an evaluation of nebulizers for better clinical outcomes. Eurasian J. Pulmonol.16, 1–7 (2014).
- Coates AL Green M Leung K et al. A comparison of amount and speed of deposition between the PARI LC STAR jet nebulizer and an investigational eFlow nebulizer. J. Aerosol. Med. Pulm. Drug Deliv.24 (3), 157–163 (2011).
- Highlights of prescribing information . Cayston (aztreonam for inhalation solution). Gilead Sciences, Inc. ; Foster City, CA, USA (2012).
- Réminiac F Vecellio L Mac Loughlin R et al. Nasal high flow nebulization in infants and toddlers: an in vitro and in vivo scintigraphic study. Pediatr Pulmonol.52 (3), 337–344 (2017).
- Ari A Atalay OT Harwood R Sheard MM Aljamhan EA Fink JB . Influence of nebulizer type, position and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care.55 (7), 845–851 (2010).
- Berlinski A Willis JR . Albuterol delivery by four different nebulizers placed in four different positions in a pediatric ventilator in vitro model. Respir Care.58 (7), 1124–1133 (2013).
- Ari A . Aerosol therapy in pulmonary critical care. Respir Care.60 (6), 858–879 (2015).
- Newman SP Pitcairn GR Hooper G Knoch M . Efficient drug delivery to the lungs from a continuously operated open-vent nebulizer and low pressure compressor system. Eur. Respir. J.7 (6), 1177–1181 (1994).
- Johnson MA Newman SP Bloom R Talaee N Clarke SW . Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma: efficacy and pulmonary deposition. Chest96 (1), 6–10 (1989).
- Brand P Beckmann H Maas Enriquez M et al. Peripheral deposition of α1-protease inhibitor using commercial inhalation devices. Eur. Respir. J.22 (2), 263–267 (2003).
- Coates AL Green M Leung K et al. Rapid pulmonary delivery of inhaled tobramycin for pseudomonas infection in cystic fibrosis: a pilot project. Pediatr. Pulmonol.43 (8), 753–759 (2008).
- Behr J Zimmermann G Baumgartner R et al. Lung deposition of a liposomal cyclosporine a inhalation solution in patients after lung transplantation. J. Aerosol. Med. Pulm. Drug Deliv.22 (2), 121–130 (2009).
- Zeman KL Wu J Bennett WD . Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations. J. Aerosol. Med. Pulm. Drug Deliv.23 (6), 363–369 (2010).
- Lenney W Edenborough F Kho P Kovarik JM . Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. J. Cyst. Fibros.10 (1), 9–14 (2011).
- Nikander K Prince I Coughlin S Warren S Taylor G . Mode of breathing–tidal or slow and deep–through the I-neb adaptive aerosol delivery (AAD) system affects lung deposition of 99mTc-DTPA. J. Aerosol. Med. Pulm. Drug Deliv.23 (Suppl. 1), S37–S43 (2010).
- Elliott D Dunne P . Guide to aerosol delivery devices for physicians, nurses, pharmacists and other healthcare professionals. Am. Assoc. Resp. Care (2011). www.aarc.org/wp-content/uploads/2014/08/aerosol_guide_pro.pdf.
- Anderson P . Patient preference for and satisfaction with inhaler devices. Eur Respir Rev.14 (96), 109–116 (2005).
- Braido F Chrystyn H Baiardini I et al. ‘Trying, But Failing’–the role of inhaler technique and mode of delivery in respiratory medication adherence. J. Allergy Clin. Immunol. Pract.4, 823–832 (2016).
- Goodman N Morgan M Nikander K Hinch S Coughlin S . Evaluation of patient-reported outcomes and quality of life with the I-neb AAD System in patients with chronic obstructive pulmonary disease. J. Aerosol. Med. Pulm. Drug Deliv.23 (Suppl. 1), S61–S70 (2010).
- Naehrig S Lang S Schiffl H Huber RM Fischer R . Lung function in adult patients with cystic fibrosis after using the eFlow Rapid for 1 year. Eur. J. Med. Res.16, 63–66 (2011).
- Rottier BL van Erp CJP Sluyter TS Heijerman HGM Frijlink HW de Boer AH . Changes in performance of the Pari eFlow Rapid and Pari LC Plus during 6 months use by CF patients. J. Aerosol. Med. Pulm. Drug Deliv.22 (3), 263–269 (2009).
- Bakuridze L Andrieu V Dupont C Dubus JC . Does repeated disinfection of the e-Flow Rapid nebulizer affect in vitro performance?J. Cyst. Fibros.6 (4), 309–310 (2007).
- Correspondence . Performance of PARI eFlow. J. Aerosol. Med. Pulm. Drug Deliv.23 (2), 113–118 (2010).
- Pritchard JN . Rethinking the paradigm for the development of inhaled drugs. Int. J. Pharm.496 (2), 1069–1072 (2015).
- Sunovion submits new drug application for SUN-1–1/eFlow to the FDA for the treatment of patients with chronic obstructive pulmonary disease (COPD) (2016). www.sunovion.us/featured-news/press-releases/.
- Vectura Group plc Corporate presentation (2017). www.vectura.com/index.php/download_file/view/548/493/.
- Pritchard JN . Nebulized drug delivery in respiratory medicine: what does the future hold?Ther. Deliv.8 (6), 391–399 (2017).